163 related articles for article (PubMed ID: 36453428)
61. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.
Shin CM; Kim N; Lee HS; Park JH; Ahn S; Kang GH; Kim JM; Kim JS; Lee DH; Jung HC
Int J Cancer; 2013 Nov; 133(9):2034-42. PubMed ID: 23595635
[TBL] [Abstract][Full Text] [Related]
62. Risk of gastric cancer among patients with gastric intestinal metaplasia.
Shao L; Li P; Ye J; Chen J; Han Y; Cai J; Lu X
Int J Cancer; 2018 Oct; 143(7):1671-1677. PubMed ID: 29707766
[TBL] [Abstract][Full Text] [Related]
63. Methylation status of blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population.
Zhang Y; Su HJ; Pan KF; Zhang L; Ma JL; Shen L; Li JY; Liu WD; Oze I; Matsuo K; Yuasa Y; You WC
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2019-26. PubMed ID: 25086101
[TBL] [Abstract][Full Text] [Related]
64. What is the role of cytokeratins in Barrett/cardia differentiation?
Younes M
Arch Pathol Lab Med; 2005 Feb; 129(2):181-2. PubMed ID: 15679416
[TBL] [Abstract][Full Text] [Related]
65. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
66. Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions.
Wang LH; Choi YL; Hua XY; Shin YK; Song YJ; Youn SJ; Yun HY; Park SM; Kim WJ; Kim HJ; Choi JS; Kim SH
Mod Pathol; 2006 May; 19(5):675-83. PubMed ID: 16528374
[TBL] [Abstract][Full Text] [Related]
67. Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.
Towle R; Truong D; Garnis C
Genes Chromosomes Cancer; 2016 Jul; 55(7):568-76. PubMed ID: 27015871
[TBL] [Abstract][Full Text] [Related]
68. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
69. Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer.
Huang KK; Ramnarayanan K; Zhu F; Srivastava S; Xu C; Tan ALK; Lee M; Tay S; Das K; Xing M; Fatehullah A; Alkaff SMF; Lim TKH; Lee J; Ho KY; Rozen SG; Teh BT; Barker N; Chia CK; Khor C; Ooi CJ; Fock KM; So J; Lim WC; Ling KL; Ang TL; Wong A; Rao J; Rajnakova A; Lim LG; Yap WM; Teh M; Yeoh KG; Tan P
Cancer Cell; 2018 Jan; 33(1):137-150.e5. PubMed ID: 29290541
[TBL] [Abstract][Full Text] [Related]
70. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea.
Kang KP; Lee HS; Kim N; Kang HM; Park YS; Lee DH; Choe G; Kim JS; Jung HC; Song IS
J Gastroenterol Hepatol; 2009 Jan; 24(1):140-8. PubMed ID: 18713298
[TBL] [Abstract][Full Text] [Related]
71. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
Companioni O; Sanz-Anquela JM; Pardo ML; Puigdecanet E; Nonell L; García N; Parra Blanco V; López C; Andreu V; Cuatrecasas M; Garmendia M; Gisbert JP; Gonzalez CA; Sala N
PLoS One; 2017; 12(4):e0176043. PubMed ID: 28441455
[TBL] [Abstract][Full Text] [Related]
72. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?
Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
Dis Esophagus; 2007; 20(1):36-41. PubMed ID: 17227308
[TBL] [Abstract][Full Text] [Related]
73. Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.
Phoa KN; Pouw RE; van Vilsteren FGI; Sondermeijer CMT; Ten Kate FJW; Visser M; Meijer SL; van Berge Henegouwen MI; Weusten BLAM; Schoon EJ; Mallant-Hent RC; Bergman JJGHM
Gastroenterology; 2013 Jul; 145(1):96-104. PubMed ID: 23542068
[TBL] [Abstract][Full Text] [Related]
74. Cigarette Smoke Regulates the Expression of EYA4 via Alternation of DNA Methylation Status.
Almutairi BO; Almutairi MH; Alrefaei AF; Ali D; Alkahtani S; Alarifi S
Biomed Res Int; 2022; 2022():5032172. PubMed ID: 35607307
[TBL] [Abstract][Full Text] [Related]
75. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
76. Characteristics of intestinal metaplasia in the gastric cardia.
El-Serag HB; Sonnenberg A; Jamal MM; Kunkel D; Crooks L; Feddersen RM
Am J Gastroenterol; 1999 Mar; 94(3):622-7. PubMed ID: 10086641
[TBL] [Abstract][Full Text] [Related]
77. Intestinal metaplasia of the gastric cardia: A prospective study with enhanced magnification endoscopy.
Guelrud M; Herrera I; Essenfeld H; Castro J; Antonioli DA
Am J Gastroenterol; 2002 Mar; 97(3):584-9. PubMed ID: 11922550
[TBL] [Abstract][Full Text] [Related]
78. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
[TBL] [Abstract][Full Text] [Related]
79. Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China.
Zhou SL; Cui J; Fan ZM; Li XM; Li JL; Liu BC; Zhang DY; Liu HY; Zhao XK; Song X; Wang R; Yan ZC; Yi HX; Wang LD
BMC Cancer; 2013 May; 13():259. PubMed ID: 23705663
[TBL] [Abstract][Full Text] [Related]
80. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia.
Duan X; Lian H; Li J; Wu B; Wang W; Wu T; Wang C; Dou Y; Zhou Z; Wang B; Xue L; Wang G
Diagn Pathol; 2019 Jun; 14(1):61. PubMed ID: 31221180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
